BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35664759)

  • 1. Evaluation of a CD13 and Integrin α
    Long Y; Shao F; Ji H; Song X; Lv X; Xia X; Liu Q; Zhang Y; Zeng D; Lan X; Gai Y
    Front Oncol; 2022; 12():884554. PubMed ID: 35664759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of a dual-receptor targeted tracer [
    Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer.
    Sun L; Gai Y; Li Z; Li H; Li J; Muschler J; Kang R; Tang D; Zeng D
    Mol Imaging Biol; 2022 Aug; 24(4):580-589. PubMed ID: 35229260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
    Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G
    Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Szabo JP; Denes N; Arato V; Racz S; Kis A; Opposits G; Kepes Z; Hajdu I; Joszai I; Emri M; Kertesz I; Mezo G; Trencsenyi G
    In Vivo; 2022; 36(4):1667-1675. PubMed ID: 35738627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of
    Yang Y; Zhang J; Zou H; Shen Y; Deng S; Wu Y
    J Cancer; 2021; 12(1):244-252. PubMed ID: 33391421
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Kis A; Szabó JP; Dénes N; Vágner A; Nagy G; Garai I; Fekete A; Szikra D; Hajdu I; Matolay O; Méhes G; Mező G; Kertész I; Trencsényi G
    Biomed Res Int; 2020; 2020():4952372. PubMed ID: 32832549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different
    Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G
    Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the monomeric [
    Israel I; Elflein K; Schirbel A; Chen K; Samnick S
    Eur J Pharm Sci; 2021 Nov; 166():105964. PubMed ID: 34375678
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G
    Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
    Medchemcomm; 2017 Mar; 8(3):673-679. PubMed ID: 30108785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of integrin α
    Dietz M; Dunet V; Mantziari S; Pomoni A; Dias Correia R; Testart Dardel N; Boughdad S; Nicod Lalonde M; Treglia G; Schafer M; Schaefer N; Prior JO
    Eur J Hybrid Imaging; 2023 Feb; 7(1):3. PubMed ID: 36720731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
    Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
    J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X
    Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003
    [No Abstract]   [Full Text] [Related]  

  • 17. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Lung Cancer and Neuroendocrine Neoplasm in a Single Scan by Targeting Both Somatostatin Receptor and Integrin αvβ3.
    Zheng Y; Wang H; Tan H; Cui X; Yao S; Zang J; Zhang L; Zhu Z
    Clin Nucl Med; 2019 Sep; 44(9):687-694. PubMed ID: 31274560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of
    Isal S; Pierson J; Imbert L; Clement A; Collet C; Pinel S; Veran N; Reinhard A; Poussier S; Gauchotte G; Frezier S; Karcher G; Marie PY; Maskali F
    EJNMMI Res; 2018 Jun; 8(1):51. PubMed ID: 29904818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.